-+ 0.00%
-+ 0.00%
-+ 0.00%

Leerink Partners Maintains Outperform on Tenet Healthcare, Raises Price Target to $264

Benzinga·02/20/2026 21:42:27
Listen to the news
Leerink Partners analyst Whit Mayo maintains Tenet Healthcare (NYSE:THC) with a Outperform and raises the price target from $255 to $264.